Shionogi is buying rare disease biotech IntraBio for $2 billion

发生了什么

The Japanese drugmaker will gain global rights to Aqneursa, a drug approved in the U.S. and E.U. for two inherited neurological disorders

摘要按规则整理自下方来源原文

来源